PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma

Gynecologic Oncology

Volumn 56, Issue 2, 1995, Pages 231-234

  Chen, Li Pai ^a   Cai, Shu Mo ^b   Fan, Jian Xuan ^b   Li, Zi Ting ^b  

^a Guangzhou Cancer Hospital   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0028935146     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1995.1037     Document Type: Article

References (19)

1. Li, M. C., Hertz, R., and Spencer, D. B. Effects of Methotrexate Therapy Upon Choriocarcinoma and Chorioadenoma, Proc. Soc. Exp. Biol. Med. 93, 361 (1956).
2. Sung, H., Xia, Z., Wu, B., and Wang, Y. 20 Years Experience In Chemotherapy of Choriocarcinoma and Malignant Mole, Chin. Med. J. 92, 677 (1979).
3. Cai, S. M., Wang, R. Y., and Ding, Y. Q. Combination Thrapy of Advanced Choriocarcinoma-An Analysis of 60 Patients, Chun-Ghua Chungliu Tsachih 8, 470 (1986).
4. Bagshawe, K. D. Risk and Prognostic Factors In Trophoblastic Neoplasia, Cancer 38, 1373 (1976).
5. Dubeshter, B., Berkowitz, R. S., Goldstein, D. P., Cramer, D. W., and Bernstein, M. Metastatic Gestational Trophoblastic Disease: Experience At The New England Trophoblastic Disease Center, 1964-1985, Obstet. Gynecol. 69, 390 (1987).
6. Lurain, J. R., Brewer, J. I., Torok, E. E., and Halpem, B. Gestational Trophoblastic Disease: Treatment Results At The Brewer Trophoblastic Disease Center, Obstet. Gynecol. 60, 354 (1982).
7. Hammond, C. B., Borchert, L. G., Tyrey, L., Creasman, W. T., and Parker, R. T. Treatment of Metastatic Trophoblastic Disease: Good and Poor Prognosis, Am. J. Obstet. Gynecol. 115, 451 (1973).
8. Surwit, E. A. Management of High-Risk Gestational Trophoblastic Disease, J. Reprod. Med. 32, 657 (1987).
9. Newlands, E. S., and Bagshawe, K. D. Epipodophyllin Derivative (Vp-16-213) In Malignant Teratomas and Choriocarcinomas, Lancet 2, 87 (1977).
10. Newlands, E. S., Rustin, G. J. S., Bagshawe, K. D., Begent, R. H. J., and Holden, L. Weekly Ema/Co Chemotherapy For High Risk Gestational Trophoblastic Tumours (Gtts), Proc. Am. Soc. Clin. Oncol. 5, 112 (1986).
11. Newlands, E. S. New Chemotherapeutic Agents In The Management of Gestational Trophoblastic Disease, Semin. Oncol. 9, 230 (1982).
12. Gordon, A. N., Kavanagh, J. J., Gershenson, D. M., Saul, P. B., Copeland, L. J., and Stringer, C. A. Cisplatin, Vinblastine, and Bleomycin Combination Therapy In Resistant Gestational Trophoblastic Disease, Cancer 58, 1407 (1986).
13. Azab, M., Droz, J. P., Theodore, C., Wolff, J. P., and Amiel, J. L. Cisplatin, Vinblastin, and Bleomycin Combination In The Treatment of Resistant High-Risk Gestational Trophoblastic Tumors, Cancer 64, 1829 (1989).
14. Miller, A. B., Hoogstraten, B., Stwuet, M., and Winkler, A. Reporting Results of Cancer Treatment, Cancer 47, 207 (1981).
15. Begent, R. H. J., and Bagshawe, K. D. The Management of High-Risk Choriocarcinoma, Semin. Oncol. 9, 198 (1982).
16. Theodore, C., Azab, M., Droz, J. P., Assouline, A., George, M., Piot, G., Bellet, D., Michel, G., and Amiel, J. L. Treatment of High-Risk Gestational Trophoblastic Disease With Chemotherapy Containing Cisplatin and Etoposide, Cancer 64, 1824 (1989).
17. Kramer, R. A., Zakher, J., and Kim, G. Role of The Glutathione Redox Cycle In Acquired and De Novo Multidrug Resistance, Science 241, 694 (1988).
18. Bradley, G., Juranka, P. F., and Ling, V. Mechanism of Multidrug Resistance, Biochim. Biophys. Acta 948, 87 (1988).
19. Ross, W. E., Sullivan, D. M., and Chow, K. C. Altered Function of Dna Topoisomerases As A Basis For Antineoplastic Drug Action, Important Adv. Oncol. 65 (1988).